Keywords: توسیلیزومب; Tumor vasoproliferativo; Bevacizumab intravÃtreo; Implante de dexametasona; Tocilizumab; Crioterapia; Vasoproliferative tumour; Intravitreal bevacizumab; Dexamethasone implant; Tocilizumab; Cryotherapy;
مقالات ISI توسیلیزومب (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: توسیلیزومب; Crystal-related arthritis; Tocilizumab;
Keywords: توسیلیزومب; Fructose; Infliximab; Tocilizumab; Blood pressure; Insulin resistance;
Keywords: توسیلیزومب; Fragility index; Giant cell arteritis; Tocilizumab; Randomized control trials; Meta-analysis;
Keywords: توسیلیزومب; Extraocular muscles; Graves' ophthalmopathy; Muscle thickness; Optical coherence tomography; Thyroid orbitopathy; Tocilizumab; Músculos extraoculares; OftalmopatÃa de Graves; Grosor muscular; TomografÃa de coherencia óptica; OrbitopatÃa tiroidea; T
Keywords: توسیلیزومب; Giant cell arteritis; Takayasu arteritis; Anti-TNF-α agents; Tocilizumab; Ustekinumab; Rituximab; Abatacept;
Keywords: توسیلیزومب; cognitive dysfunction; cytokines; interleukin-6 (IL-6); surgery; tocilizumab;
Keywords: توسیلیزومب; Rheumatoid arthritis; Portal hypertension; Tocilizumab; Efficacy; Safety;
Keywords: توسیلیزومب; AZA; azathioprine; ADA; adalimumab; CYA; cyclosporine A; CYX; cyclophosphamide; ETN; etanercept; FK; tacrolimus; IFX; infliximab; IS; immunosuppressant; LFM; leflunomide; MMF; mycophenolate mofetil; MTX; methotrexate; RTX; rituximab; TAK; Takayasu's Arter
Keywords: توسیلیزومب; Interleukin-6; Humanized anti-IL-6 receptor antibody; Tocilizumab; Chimeric anti-IL-6 antibody; Siltuximab; Multicentric Castleman disease; IL-6 blocking therapy;
Keywords: توسیلیزومب; Castleman disease; Treatment; Rituximab; Corticosteroids; Chemotherapy; Tocilizumab; Siltuximab;
Keywords: توسیلیزومب; Polymyalgia rheumatica; Giant cell arteritis; Temporal artery biopsy; Corticosteroids; Tocilizumab;
Keywords: توسیلیزومب; RA; rheumatoid arthritis; TCZ; tocilizumab; TOFA; tofacitinib citrate; MTX; methotrexate; DMARD; disease-modifying antirheumatic drug; bDMARD; biologic disease-modifying antirheumatic drug; nbDMARD; non-biologic disease-modifying antirheumatic drug; obDMA
Keywords: توسیلیزومب; Myasthenia gravis; Immunomodulatory therapy; Rituximab; Tocilizumab;
Keywords: توسیلیزومب; Acute lymphoblastic leukemia; ALL; Blinatumomab; CAR; Chimeric antigen receptor; CRS; Cytokine release syndrome; IL-6; Tocilizumab;
Keywords: توسیلیزومب; Immunogenicity; Tocilizumab; Rheumatoid arthritis;
Keywords: توسیلیزومب; Cardiovascular risk; Rheumatoid arthritis; IL-6 blockade; Tocilizumab;
Keywords: توسیلیزومب; Tocilizumab; IL-6; Microglia; Astrocyte; Osteoarthritis;
Keywords: توسیلیزومب; Autoimmune uveitis; Interleukin-6; Biologic therapy; Tocilizumab;
Keywords: توسیلیزومب; Juvenile idiopathic arthritis; Uveitis; Adalimumab; Tocilizumab; Biologics;
Keywords: توسیلیزومب; Skin cancer; Anti-TNF/TNF inhibitors; Biologic therapies; Lymphoma; Abatacept; Rituximab; Tocilizumab;
Keywords: توسیلیزومب; MTX; methotrexate; TNF; tumor necrosis factor; IL; interleukin; CTLA4; cytotoxic T-lymphocyte antigen 4; IFX; infliximab; ADA; adalimumab; GLM; golimumab; CZP; certolizumab pegol; ETN; etanercept; TCZ; tocilizumab; ABA; abatacept; RTX; rituximab; UTK; ust
Keywords: توسیلیزومب; IL-6; Rheumatoid arthritis; Cytokines; Tocilizumab; Immunological factors; Biologics
Keywords: توسیلیزومب; Giant cell arteritis; Cardiovascular disease; Thromboembolic disease; Glucocorticoid; Tocilizumab; Autoimmune disease; Systemic inflammatory disease;
Keywords: توسیلیزومب; Castleman's disease; Multicentric Castleman's disease; Angiofollicular lymph node hyperplasia; Human immunodeficiency virus; Human herpes virus 8; Rituximab; Tocilizumab; SiltuximabEnfermedad de Castleman; Enfermedad de Castleman multicéntrica; Hiperplasi
Keywords: توسیلیزومب; Enfermedad de Castleman; Enfermedad de Castleman multicéntrica; Hiperplasia linfoide angiofolicular; Virus de la inmunodeficiencia humana; Virus del herpes humano tipo 8; Rituximab; Tocilizumab; SiltuximabCastleman's disease; Multicentric Castleman's dise
Keywords: توسیلیزومب; Monoclonal antibodies; Tocilizumab; Alirocumab; Evolocumab; Reticuloendothelial system; IL-6; PCSK9; Methotrexate; Simvastatin;
Keywords: توسیلیزومب; Tocilizumab; Rheumatoid arthritis; GALNT18; CD69; Effectiveness;
Keywords: توسیلیزومب; Tocilizumab; Elderly; Rheumatoid arthritis; Efficacy; Drug survival
Keywords: توسیلیزومب; Hypersensitivity reactions; Drug allergy; Anaphylaxis; Biological agents; Monoclonal antibodies; Tryptase; Epinephrine; Skin testing; Rapid desensitization; AS; Ankylosing spondylitis; ASA; Acetylsalicylic acid; BAT; Basophil activation test; CD; Crohn's
Keywords: توسیلیزومب; IL-6; Autoimmunity; Inflammation; Tocilizumab
Keywords: توسیلیزومب; Interleukin-6 (IL-6); Metabolic disease; IL-6; interleukin-6; MS; metabolic syndrome; ROS; reactive oxygen species; IFN; interferon; hIL-6; human interleukin-6; SHP-2; Src homology domain-containing protein tyrosine phosphatase-2; IR; insulin resistance;
Keywords: توسیلیزومب; Pregnancy outcome; Spontaneous abortion; Tocilizumab; Rheumatoid arthritis; Birth defects; Biologic disease-modifying antirheumatic drugsTCZ, tocilizumab; Mab, monoclonal antibody; IL-6, interleukin-6-receptor; RA, rheumatoid arthritis; MTX, methotrexate;
Keywords: توسیلیزومب; Tocilizumab; Viral load; Epstein-Barr virus (EBV); Cytomegalovirus (CMV); Varicella-zoster virus (VZV); Rheumatoid arthritis (RA)
Keywords: توسیلیزومب; Behcet’s disease; Corticosteroids; Interleukin-6; Tocilizumab; Uveitis
Disseminated cryptococcosis in a patient taking tocilizumab for Castleman's disease
Keywords: توسیلیزومب; Castleman's disease; Disseminated cryptococcosis; Tocilizumab; Liposomal amphotericin B; Fluconazole;
Incidence of paradoxical reactions in patients treated with tocilizumab for rheumatoid arthritis: Data from the French registry REGATE
Keywords: توسیلیزومب; Tocilizumab; Paradoxical reactions; Rheumatoid arthritis; Vasculitis; Lupus; Uveitis;
Blau syndrome with good Reponses to Tocilizumab: A case report and focused literature review
Keywords: توسیلیزومب; Blau syndrome; Tocilizumab; Biological agents;
The effect of non-TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis
Keywords: توسیلیزومب; Type 2 diabetes; Insulin resistance; Beta-cell; Abatacept; Anakinra; Tocilizumab;
Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis
Keywords: توسیلیزومب; Cytomegalovirus (CMV); Ebstein-Barr virus (EBV); Tocilizumab; Viral load; Rheumatoid arthritis;
Efficacité et tolérance du tocilizumab en traitement d'épargne cortisonique dans l'artérite à cellules géantes et les aortites : expérience du centre hospitalier de Nîmes à propos de onze patients
Keywords: توسیلیزومب; Artérite à cellules géantes; Corticothérapie; Corticodépendant; Tocilizumab; Aortite; Giant cell arteritis; Steroid therapy; Steroid dependent; Tocilizumab; Aortitis;
Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients
Keywords: توسیلیزومب; Takayasu arteritis; Tocilizumab; Vasculitis treatment;
Hypofibrinogénémie induite par le tocilizumab : 7 cas
Keywords: توسیلیزومب; Tocilizumab; Interleukine-6; Biothérapie; Hypofibrinogénémie;
Interleukin-6 receptor inhibition with tocilizumab induces a selective and substantial increase in plasma IP-10 and MIP-1β in non-ST-elevation myocardial infarction
Keywords: توسیلیزومب; Tocilizumab; Interleukin-6; Inflammation; Myocardial infarction; IP-10; MIP-1β;
Soluble CD163, a unique biomarker to evaluate the disease activity, exhibits macrophage activation in systemic juvenile idiopathic arthritis
Keywords: توسیلیزومب; Soluble CD163; Systemic juvenile idiopathic arthritis; Tocilizumab; Macrophage activation syndrome;
Immunogénicité du tocilizumab chez des patients atteints de polyarthrite rhumatoïde
Keywords: توسیلیزومب; Immunogénicité; Tocilizumab; Polyarthrite rhumatoïde;
Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide
Keywords: توسیلیزومب; Takayasu arteritis; Tocilizumab; Cyclophosphamide; IL-6; MMP-9; Treatment effect;
The combination of IL-6 and its soluble receptor is associated with the response of rheumatoid arthritis patients to tocilizumab
Keywords: توسیلیزومب; Rheumatoid arthritis; IL-6; sIL-6R; Tocilizumab;
Effet du tocilizumab sur la dépense énergétique dans la polyarthrite rhumatoïde : étude prospective utilisant la calorimétrie et l'actimétrie
Keywords: توسیلیزومب; Polyarthrite rhumatoïde; Dépense énergétique de repos; Activité physique; Tocilizumab; Interleukine-6; Masse maigre (fat free mass [FFM]);
Contrairement au tocilizumab, l'étanercept augmente légèrement l'agrégation plaquettaire expérimentale induite par la thrombine chez les sujets sains
Keywords: توسیلیزومب; Plaquette; Inflammation; Tocilizumab; Ãtanercept; Polyarthrite rhumatoïde;